Literature DB >> 14734784

Epithelial barriers, compartmentation, and cancer.

J M Mullin1.   

Abstract

Epithelial cells, and the tight junctions between them, form a polarized barrier between luminal and serosal fluid compartments and segregate luminal growth factors from their basal-lateral receptors. Breakdown of this barrier should allow access of growth factors in the luminal fluid to their receptors on the basal-lateral cell membranes, as recently demonstrated for heregulin and erbB receptors in airway epithelia. It should also allow luminal growth factors to access the stroma. This property may have adaptive value for epithelial tissues in general, as an elegant response to injury, but may also promote cancer formation in premalignant epithelial tissues in which the tight junctions have become chronically leaky to growth factors.

Entities:  

Mesh:

Year:  2004        PMID: 14734784     DOI: 10.1126/stke.2162004pe2

Source DB:  PubMed          Journal:  Sci STKE        ISSN: 1525-8882


  29 in total

1.  Raised intensity phonation compromises vocal fold epithelial barrier integrity.

Authors:  Bernard Rousseau; Atsushi Suehiro; Nicholas Echemendia; Mahalakshmi Sivasankar
Journal:  Laryngoscope       Date:  2011-01-13       Impact factor: 3.325

2.  Ras mutation impairs epithelial barrier function to a wide range of nonelectrolytes.

Authors:  James M Mullin; James M Leatherman; Mary Carmen Valenzano; Erika Rendon Huerta; Jon Verrechio; David M Smith; Karen Snetselaar; Mantao Liu; Mary Kay Francis; Christian Sell
Journal:  Mol Biol Cell       Date:  2005-09-21       Impact factor: 4.138

3.  Expression of tight and adherens junction proteins in ulcerative colitis associated colorectal carcinoma: upregulation of claudin-1, claudin-3, claudin-4, and beta-catenin.

Authors:  S T Mees; R Mennigen; T Spieker; E Rijcken; N Senninger; J Haier; M Bruewer
Journal:  Int J Colorectal Dis       Date:  2009-01-29       Impact factor: 2.571

4.  Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the apical membrane of polarized epithelia.

Authors:  Fabiana C Morales; Yoko Takahashi; Erica L Kreimann; Maria-Magdalena Georgescu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-10       Impact factor: 11.205

5.  The detection of EBP50 expression using quantum dot immunohistochemistry in pancreatic cancer tissue and down-regulated EBP50 effect on PC-2 cells.

Authors:  Meng-Yao Ji; Di-kun Fan; Xiao-Guang Lv; Xiu-Lan Peng; Xiao-Fei Lei; Wei-Guo Dong
Journal:  J Mol Histol       Date:  2012-05-24       Impact factor: 2.611

6.  Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis.

Authors:  Adam H Johnson; Henry F Frierson; Alexander Zaika; Steven M Powell; James Roche; Sheila Crowe; Christopher A Moskaluk; Wa'el El-Rifai
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

7.  NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane.

Authors:  Maria-Magdalena Georgescu; Gilbert Cote; Nitin Kumar Agarwal; Charles L White
Journal:  Neoplasia       Date:  2014-04       Impact factor: 5.715

8.  Regulation of renal epithelial tight junctions by the von Hippel-Lindau tumor suppressor gene involves occludin and claudin 1 and is independent of E-cadherin.

Authors:  Sarah K Harten; Deepa Shukla; Ravi Barod; Alexander Hergovich; Maria S Balda; Karl Matter; Miguel A Esteban; Patrick H Maxwell
Journal:  Mol Biol Cell       Date:  2008-12-10       Impact factor: 4.138

9.  Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases.

Authors:  Xiying Shang; Xinjian Lin; Edwin Alvarez; Gerald Manorek; Stephen B Howell
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

10.  Differential effects of EGFR ligands on endocytic sorting of the receptor.

Authors:  Kirstine Roepstorff; Michael Vibo Grandal; Lasse Henriksen; Stine Louise Jeppe Knudsen; Mads Lerdrup; Lene Grøvdal; Berthe Marie Willumsen; Bo van Deurs
Journal:  Traffic       Date:  2009-05-19       Impact factor: 6.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.